Interpace Biosciences to Explore Strategic Alternatives for Maximizing Shareholder Value Apr 22, 2021
Interpace Biosciences Announces New PLA Code and Medicare Reimbursement Increase for Proprietary Thyroid Assay, ThyGeNEXT® Apr 5, 2021
Interpace Biosciences Announces Full Year and Fourth Quarter 2020 Financial and Business Results Mar 31, 2021
Interpace Biosciences and XIFIN Forge Strategic Partnership to Improve Financial Performance Mar 9, 2021
Interpace Biosciences Announces Contract for Thyroid Testing with Blue Cross Blue Shield of Illinois Feb 25, 2021
